Lytic and latent EBV gene expression in transplant recipients with and without post-transplant lymphoproliferative disorder.

Abstract

Epstein-Barr virus (EBV) is associated with post-transplant lymphoproliferative disorder (PTLD), which has significant morbidity and mortality in transplant recipients. To devise prophylactic measures, we need predictors of PTLD and a better understanding of the physiopathogenesis of the disease.